The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
| Autor: | Goker Bagca, Bakiye *, Biray Avci, Cigir |
|---|---|
| Zdroj: | In Cytokine and Growth Factor Reviews August 2020 54:51-62 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
| Autor: | Goker Bagca, Bakiye *, Biray Avci, Cigir |
|---|---|
| Zdroj: | In Cytokine and Growth Factor Reviews August 2020 54:51-62 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect